Hi Everyone,
On this snowy morning in New England, with a recent increase in dose to 135 mcg, I was trying to understand side effects of Pegasys. As I read about the accompanying pegasys literature to my vials, it occurred to me how loose the analysis is when a drug is "off spec" for a particular disease as the literature was for treatment of hepatitis. So it occurred to me that even if I continue to use Pegasys, the literature for Besremi seems very relevant as they studied a similar drug with patients who actually had polycythemia vera. Sure enough I typed in on my browser "besremi prescribing info" and found a document (Highlights of Prescribing Information) that seems more relevant (with some limitations I guess). The adverse reaction table seemed much more meaningful. I am sure I will be switching as some point to Besremi, but for now...
Any thoughts? Anything I missed?
Thanks, Steve